Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
517
datasets available to search
ShareScore release 0.9.0
Dataset results
517 results for “Checkpoint inhibitors”
Prospective Study to Evaluate the Blood Kinetics of Immune Cells and Immunosuppressive Cytokines After Exposure to an Immunity Checkpoint Inhibitor (ICI): Study of the Impact of Chemotherapy
ClinicalTrials.gov study NCT04487457. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Discovery of Biomarkers Related to the Efficacy and Adverse Reactions of Immune Checkpoint Inhibitors Based on Metabolism-genomics
ClinicalTrials.gov study NCT04656119. IPD Sharing: NO. Countries: 1. Publications: 0.
SYSTEMATIC SYMPTOM ASSESSMENT IN CANCER PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS
ClinicalTrials.gov study NCT04929353. IPD Sharing: NO. Countries: 1. Publications: 0.
SBRT for Oligoprogressive NSCLC After First Line Treatment With Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT05387044. IPD Sharing: NO. Countries: 1. Publications: 0.
Liver Toxicity in Lung Cancer Patients Treated With Immune-checkpoint Inhibitors.
ClinicalTrials.gov study NCT04595734. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Development of an EORTC Immune Checkpoint Inhibitor-specific Quality of Life Item List: Phase 1 & 2
ClinicalTrials.gov study NCT05554432. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy of Torque Teno Virus as a Biomarker for Predicting Treatment Response of Immune Checkpoint Inhibitor Therapy and Postoperative Outcome in NSCLC Patients
ClinicalTrials.gov study NCT06967532. IPD Sharing: YES. Countries: 1. Publications: 0.
CAN-2409 Plus Prodrug With Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLC
ClinicalTrials.gov study NCT04495153. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Qualitative Assessment of the Severity and Impact of Rheumatic Immune-Related Adverse Events Following Immune Checkpoint Inhibitor Immunotherapy
ClinicalTrials.gov study NCT06647134. IPD Sharing: Not stated. Countries: 1. Publications: 0.
HLA-G Immuno-Inhibitor Checkpoint Study in Patients With COVID-19 Infection: Molecular and Cellular Assessment
ClinicalTrials.gov study NCT04613297. IPD Sharing: NO. Countries: 1. Publications: 0.
Immune Checkpoint Inhibitor PD-1 Antibody Combined With Chemotherapy in the Perioperative Treatment of Locally Advanced Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
ClinicalTrials.gov study NCT04908566. IPD Sharing: YES. Countries: 1. Publications: 0.
Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors
ClinicalTrials.gov study NCT04262466. IPD Sharing: Not stated. Countries: 17. Publications: 0.
Biomarkers for Clinical Classification and Outcomes of Immune Checkpoint Inhibitor-Related-Related Myocarditis in Lung Cancer
ClinicalTrials.gov study NCT06818149. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Radiomics to Identify Patients at Risk for Developing Pneumonitis, Differentiate Immune Checkpoint Inhibitor-induced Pneumonitis From Other Lung Inflammation and Distinguish Tumour Pseudo-progression
ClinicalTrials.gov study NCT03305380. IPD Sharing: NO. Countries: 1. Publications: 0.
Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT04615988. IPD Sharing: NO. Countries: 1. Publications: 0.
Immune Checkpoint Inhibitor Associated Cardiovascular Adverse Events in Patients With Cancer
ClinicalTrials.gov study NCT06519292. IPD Sharing: NO. Countries: 1. Publications: 0.
Cognitive Function in Melanoma Patients Treated With Adjuvant Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT04565769. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Long-Term Quality of Life in Patients With Metastatic Melanoma Treated With Checkpoint Inhibitors
ClinicalTrials.gov study NCT03326973. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Assessment of Myocardial Injury in Patients Treated With Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT05349058. IPD Sharing: NO. Countries: 1. Publications: 0.
Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma
ClinicalTrials.gov study NCT04974671. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.